Our results suggest that robustness in the association of OPRD1 CpG3 with AD, although we can exclude a chance that drugs may influence peripheral blood DNA methylation patterns by changing the cell type composition in blood [55]. This evidence concerns the gene OPRD1 and Alzheimer disease.